Connect with us


Senasa Was Present at the Expo Cannabis 2022 in Palermo

At Expo Cannabis 2022, Senasa representatives received several queries related to cannabis and hemp production at a stand, which was shared with the National Secretary of Agriculture, INTA, and Inase. Specifically related to the registration of fertilizers, bio-inputs, amendments, fields for production, registration of the Cannabis Program (REPROCANN) of the National Ministry of Health.



The National Agri-Food Health and Quality Service (Senasa) actively participated in the third edition of the Expo Cannabis 2022 held at the Rural Fairgrounds in Palermo from November 4th to 6th, with a stand staffed by specialists and technicians, who advised the public on the development of the medical cannabis and industrial hemp industry and explained the actions of the Agency’s Strategic Board.

Within this framework, on Saturday, November 5th, the President of Senasa, Diana Guillén, together with the National Director of Federal Articulation of INASE, Gabriel Giménez, gave a conference on “Registration and Trade of Cannabis Seeds and Plants”, where she highlighted the work of organizations such as Mamá Cultiva, and the advances in regulatory matters for the uses of medical cannabis and industrial hemp and emphasized, in relation to the role of Senasa, the accompaniment and support to this developing industry in different regions of the country.

“We have the decision to move forward with regard to Senasa’s competencies, together with the National Secretary of Agriculture, INASE and INTA, so that the rights established by the new regulatory frameworks can be exercised. The rights, if they are not exercised, remain only on paper or in a library,” said Guillén during her presentation.

The head of the Agency, who was also accompanied by the coordinator of Senasa’s Strategic Roundtable on Cannabis and Industrial Hemp, Diego Peña, also recalled: “The growth of the cannabis and hemp industry is a collective construction, between the different State agencies, the private sector and civil society organizations”.

Another of the topics addressed by Guillén were traceability in the process of control and commercialization of cannabis, registration, and trade of seeds, in the space called “Industry and Cultivation”.

On Friday, November 4th, Sebastián Gomez, agronomist engineer of the National Directorate of Plant Protection, gave a lecture on the regulatory framework for the registration of products for crop health and fertility at Senasa.

Read more about the Expo Cannabis 2022 and find the latest cannabis news in the world with the mobile app.

Consultations from the public

Senasa representatives received several queries related to cannabis and hemp production at a stand, which was shared with the National Secretary of Agriculture, INTA, and Inase. Specifically related to the registration of fertilizers, bio-inputs, amendments, fields for production, registration of the Cannabis Program (REPROCANN) of the National Ministry of Health (National Registry of persons authorized to cultivate controlled crops for medicinal and/or therapeutic purposes), the use of medicinal cannabis in animals and the role of Senasa throughout the production chain.

The presence of Senasa in exhibitions such as this one, responds to the objective of bringing its work closer to the community as a whole. For example, during 2022, the Agency also participated in Agroactiva and Expoagro, and in the traditional exhibition of La Rural de Palermo, among other conferences and exhibitions related to the agricultural and agri-food sectors, providing details of its actions for the benefit of the national sanitary heritage, food safety, local and international consumers and producers.

The Cannabis Expo

The event, with more than 200 stands, brought together medical speakers, scientists, consumers, producers, and entrepreneurs in a mega-exhibition that dealt with the medicinal and recreational use of cannabis, as well as the exploitation of its industry and new developments, and included workshops, a space for children and personalized consultations.

Among the personalities that were present on behalf of the national government were the Minister of Health of the Nation, Carla Vizzotti; the Secretary of Agriculture of the Nation, Juan José Bahillo; Guillén and authorities of INTA and INASE.

At the most important event on medicinal, industrial and adult-use cannabis in Latin America, all the products and services of the sector in Argentina were exhibited.

The great novelties this year were the new products that will be available, a cannabis cooking course, and technological advances. There were also more than 80 conferences and workshops on two simultaneous stages, medical, veterinary, and legal clinics, scientific posters, live art, games for children, and a large food court.

This year there were more than 450 national and international brands from the United States, Germany, Holland, Poland, Austria, Spain, Mexico, Brazil, Chile and Uruguay. The stands were distributed in more than 15 thousand square meters covered, in 2 thematic pavilions: one exclusively for medical cannabis and the other for cultivation, use, and industry.

A wide range of products for the use of cannabis, vaporizers, growing supplies, new lighting, irrigation, and climate management technologies for home and industrial crops, devices to analyze the composition of buds and oils, and industrial machinery for different processes, among many other products and services, could be found there.

Expo Cannabis had a pavilion dedicated exclusively to medical cannabis, with equipment and service companies, pharmaceutical laboratories, public and private projects, and universities. In the general pavilion, there was a second simultaneous stage where conferences on cultivation, cannabis strains, industry, economy, legal contexts, and technology were held.

There were also forums for debate and round tables with the presence of the main players in the sector: producers, scientists, academics, growers, businessmen, and public officials.


(Featured image by Kindel Media via Pexels)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Helene Lindbergh is a published author with books about entrepreneurship and investing for dummies. An advocate for financial literacy, she is also a sought-after keynote speaker for female empowerment. Her special focus is on small, independent businesses who eventually achieve financial independence. Helene is currently working on two projects—a bio compilation of women braving the world of banking, finance, crypto, tech, and AI, as well as a paper on gendered contributions in the rapidly growing healthcare market, specifically medicinal cannabis.